Long-term high-intensity interval training increases serum neurotrophic factors in elderly overweight and obese Chinese adults

Purpose To compare the effects of 12-week high-intensity interval training (HIIT) and vigorous-intensity continuous training (VICT) on cognitive function, physical fitness, VO 2 max, serum neurotransmitters and neurotrophic factors in overweight and obese elderly individuals. Methods Twenty-nine phy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of applied physiology 2021-10, Vol.121 (10), p.2773-2785
Hauptverfasser: Li, Xi, Han, Tianyu, Zou, Xu, Zhang, Han, Feng, Wenpin, Wang, Han, Shen, Yulin, Zhang, Li, Fang, Guoliang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To compare the effects of 12-week high-intensity interval training (HIIT) and vigorous-intensity continuous training (VICT) on cognitive function, physical fitness, VO 2 max, serum neurotransmitters and neurotrophic factors in overweight and obese elderly individuals. Methods Twenty-nine physically inactive older adults (18 males and 11 females) with a mean age of 64.8 ± 3.9 years were randomly divided into a control group (CON, n  = 9), an HIIT group (4 × 3 min at 90% VO 2 max interspersed with 3 min at 60% VO 2 max, n  = 10) and a VICT group (25 min at 70% VO 2 max, n  = 10) and submitted to 12 weeks of training. Cognitive function questionnaires, physical fitness, VO 2 max, serum neurotransmitters and neurotrophic factors were determined at baseline and post training. Results Twelve weeks of HIIT and VICT improved the VO 2 max (4.19 ± 2.21 and 1.84 ± 1.63 mL/kg/min, respectively, p  = 0.005), sit-and-reach distance (8.7 ± 3.0 and 7.8 ± 3.8 cm, p  = 0.033), choice reaction time (− 0.115 ± 0.15 and − 0.09 ± 0.15 s, p  = 0.004) and one-leg stand time (4.4 ± 3.4 and 4.2 ± 4.0 s, p   0.05). Conclusion HIIT is suitable for elderly adults and is more effective than VICT for improving VO 2 max and serum neurotrophin-3 concentrations. Chinese Clinical Trial Registry number No. ChiCTR1900022315, date of registration: 4 April 2019
ISSN:1439-6319
1439-6327
DOI:10.1007/s00421-021-04746-w